Cogent Biosciences Ownership | Who Owns Cogent Biosciences?


OverviewForecastRevenueFinancialsChart

Cogent Biosciences Ownership Summary


Cogent Biosciences is owned by 122.30% institutional investors, 0.13% insiders. Point72 asset management is the largest institutional shareholder, holding 10.55% of COGT shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.82% of its assets in Cogent Biosciences shares.

COGT Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockCogent Biosciences122.30%0.13%-22.42%
SectorHealthcare Stocks 47.31%8.01%44.69%
IndustryBiotech Stocks 45.43%7.81%46.75%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Point72 asset management10.47M10.55%$88.27M
Commodore capital lp9.74M9.81%$82.09M
Kynam capital management, lp9.26M9.33%$78.07M
Fmr7.69M7.75%$64.86M
Blackrock7.29M7.34%$61.44M
Tcg crossover management6.96M7.02%$58.71M
Fairmount funds management6.23M6.27%$52.48M
Vr adviser5.68M5.73%$47.92M
Vanguard group5.26M5.30%$44.34M
Redmile group4.80M4.84%$40.46M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Tcg crossover management6.96M6.12%$58.71M
Kynam capital management, lp9.26M6.02%$78.07M
Fairmount funds management6.23M5.93%$52.48M
Commodore capital lp9.74M5.60%$82.09M
Saturn v capital management1.67M5.33%$14.11M
Vr adviser5.68M3.05%$47.92M
New leaf venture partners250.76K2.57%$2.11M
Redmile group4.80M2.45%$40.46M
Silverarc capital management1.21M2.40%$10.17M
Vivo capital2.24M1.75%$18.92M

Top Buyers

HolderShares% AssetsChange
Point72 asset management10.47M0.23%3.79M
Paradigm biocapital advisors lp3.62M1.17%3.62M
Commodore capital lp9.74M5.60%3.31M
Adage capital partners gp4.25M0.07%2.92M
Deerfield management company, l.p. (series c)3.74M0.53%2.21M

Top Sellers

HolderShares% AssetsChange
State street3.84M0.00%-3.79M
Janus henderson group15.77K0.00%-2.08M
Perceptive advisors---883.33K
Morgan stanley981.64K0.00%-869.07K
Readystate asset management lp---734.20K

New Positions

HolderShares% AssetsChangeValue
Paradigm biocapital advisors lp3.62M1.17%3.62M$30.55M
Franklin resources1.00M0.00%1.00M$8.43M
Hennion & walsh asset management127.71K0.06%127.71K$1.08M
Alps advisors74.60K0.00%74.60K$628.86K
Corebridge financial49.37K0.00%49.37K$416.16K

Sold Out

HolderChange
Nelson, van denburg & campbell wealth management group-16.00
Yhb investment advisors-50.00
Innealta capital-86.00
Us bancorp \de\-137.00
Quadrant capital group-689.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 2024151-3.21%121,368,54811.09%1220.92%79-20.20%4837.14%
Mar 31, 20241564.70%109,251,85420.30%1151.05%992.06%3516.67%
Dec 31, 20231497.97%90,815,313-0.05%1040.94%9738.57%30-14.29%
Sep 30, 20231380.73%90,861,4072.34%1050.75%70-10.26%35-7.89%
Jun 30, 20231370.74%88,785,30417.96%1181.05%7834.48%38-15.56%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv3.09M2.82%-
iShares Russell 2000 ETF2.37M2.17%-5.33K
FIAM Small Cap Core CIT Cl B1.55M1.42%20.10K
Vanguard Institutional Extnd Mkt Idx Tr1.55M1.41%318.05K
FIAM Small Cap Core Composite1.52M1.38%1.52M
Eventide Healthcare & Life Sciences I1.40M1.28%1.40M
Fidelity Series Small Cap Opps1.39M1.27%-51.10K
Fidelity Select Biotechnology1.38M1.26%19.97K
Fidelity Advisor Biotechnology I1.33M1.22%-
SPDR® S&P Biotech ETF1.25M1.15%13.86K

Recent Insider Transactions


DateNameRoleActivityValue
Jun 09, 2023Fairmount Funds Management LLC-Buy$9.60M
Jun 16, 2022Fairmount Funds Management LLC Buy$9.90M
Apr 26, 2021Green John L. Chief Financial OfficerSell$157.82K
Apr 26, 2021Green John L. Chief Financial OfficerSell$157.82K
Apr 06, 2020CAMPANA DARIO-Sell$17.53K

Insider Transactions Trends


DateBuySell
2024 Q4--
2024 Q3--
2024 Q2--
2024 Q1--
2023 Q4--

COGT Ownership FAQ


Who Owns Cogent Biosciences?

Cogent Biosciences shareholders are primarily institutional investors at 122.30%, followed by 0.13% insiders and -22.43% retail investors. The average institutional ownership in Cogent Biosciences's industry, Biotech Stocks , is 45.43%, which Cogent Biosciences exceeds.

Who owns the most shares of Cogent Biosciences?

Cogent Biosciences’s largest shareholders are Point72 asset management (10.47M shares, 10.55%), Commodore capital lp (9.74M shares, 9.81%), and Kynam capital management, lp (9.26M shares, 9.33%). Together, they hold 29.69% of Cogent Biosciences’s total shares outstanding.

Does Blackrock own Cogent Biosciences?

Yes, BlackRock owns 7.34% of Cogent Biosciences, totaling 7.29M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 61.44M$. In the last quarter, BlackRock increased its holdings by 598.76K shares, a 8.95% change.

Who is Cogent Biosciences’s biggest shareholder by percentage of total assets invested?

Tcg crossover management is Cogent Biosciences’s biggest shareholder by percentage of total assets invested, with 6.12% of its assets in 6.96M Cogent Biosciences shares, valued at 58.71M$.

Who is the top mutual fund holder of Cogent Biosciences shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Cogent Biosciences shares, with 2.82% of its total shares outstanding invested in 3.09M Cogent Biosciences shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools